Center For Sight
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Center For Sight sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Center For Sight: 5 sponsored US clinical trials, 3 recruiting.
Center For Sight sponsors 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 2 completed. 3 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Pseudophakia, with 1 trials.
Upper-quartile sponsor footprint
Center For Sight sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
Evaluating a New Therapy for Dry Eye in Patients With Sjögren's Syndrome
NCT07277257
Arcuate Incisions With Light Adjustable Lens for Astigmatism Correction in Lens Surgery
NCT07140653
Odyssey Evaluation in Post LASIK Patients
NCT07260695
Symfony/Synergy IOL Combination Outcomes
NCT05604781
Synergy Lens Outcomes Evaluation
NCT05418153
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 3 |
Therapeutic Areas
Where Center For Sight enrollment is open (later-stage tilt)
3 recruiting of 5 indexed (60% open); 2 completed (40%).
Phase mix: 3 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Pseudophakia (1 trial), 4 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Center For Sight: open-pipeline peers nationwide
Peers matched on 5 registered trials and 60% open enrollment, not the therapeutic-area sidebar.
Center For Sight sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 60% open enrollment (± trial volume)
- Alaska Native Tribal Health Consortium · 60% recruiting · 5 trials
- Anwaar Saeed · 60% recruiting · 5 trials
- Autolus Limited · 60% recruiting · 5 trials
- Beam Therapeutics · 60% recruiting · 5 trials
Related
What to do with this Center For Sight page
5 registered trials is a research-attention snapshot, not an endorsement of Center For Sight or any single study.
- 3 of Center For Sight's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Pseudophakia is the condition Center For Sight studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pseudophakia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Center For Sight pipeline card: 5 registered trials from official public datasets.Report a data error.